UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces

The Journal of biological chemistry, 1993-04, Vol.268 (12), p.8704-8710

1993

Volltextzugriff (PDF)

Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven)

Blood coagulation & fibrinolysis, 2000-04, Vol.11 Suppl 1, p.S159-S164

2000

Volltextzugriff (PDF)

Effect of leukocyte proteinases on tissue factor pathway inhibitor

Thrombosis and haemostasis, 1992-05, Vol.67 (5), p.537-541

1992

Volltextzugriff (PDF)

Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A

Blood coagulation & fibrinolysis, 1995-07, Vol.6 (5), p.388-394

1995

Volltextzugriff (PDF)

Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions

The Journal of biological chemistry, 1990-10, Vol.265 (28), p.16786-16793

1990

Volltextzugriff (PDF)

The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits

Blood coagulation & fibrinolysis, 1993-10, Vol.4 (5), p.699-706

1993

Volltextzugriff (PDF)

Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae

The Journal of biological chemistry, 1993-06, Vol.268 (18), p.13344-13351

1993

Volltextzugriff (PDF)

Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven

Blood coagulation & fibrinolysis, 2000-04, Vol.11 (3), p.239

2000

Volltextzugriff (PDF)

Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa

The Journal of biological chemistry, 1992-01, Vol.267 (2), p.876-882

1992

Volltextzugriff (PDF)

Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins

Blood coagulation & fibrinolysis, 1993-10, Vol.4 (5), p.713-720

1993

Volltextzugriff (PDF)

Generation of active coagulation factor VIII from isolated subunits

The Journal of biological chemistry, 1988-01, Vol.263 (3), p.1115-1118

1988

Volltextzugriff (PDF)

Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma

Thrombosis and haemostasis, 1991, Vol.66 (4), p.464-467

1991

Volltextzugriff (PDF)

Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin

Thrombosis and haemostasis, 1994-02, Vol.71 (2), p.214

1994

Volltextzugriff (PDF)

Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa

Thrombosis and haemostasis, 1995-12, Vol.74 (6), p.1478-1485

1995

Volltextzugriff (PDF)

Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits

Thrombosis and haemostasis, 1993, Vol.70 (3), p.454-457

1993

Volltextzugriff (PDF)

Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin

Blood coagulation & fibrinolysis, 1992-04, Vol.3 (2), p.221-222

1992

Volltextzugriff (PDF)

The significance of TFPI in clotting assays--comparison and combination with other anticoagulants

Thrombosis and haemostasis, 1993-09, Vol.70 (3), p.448

1993

Volltextzugriff (PDF)

Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin

Thrombosis and haemostasis, 1992, Vol.68 (3), p.310-314

1992

Volltextzugriff (PDF)

The functional domains of coagulation factor VIII:C

The Journal of biological chemistry, 1986-09, Vol.261 (27), p.12574-12578

1986

Volltextzugriff (PDF)

Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays

Blood coagulation & fibrinolysis, 1991-10, Vol.2 (5), p.629-636

1991

Volltextzugriff (PDF)

Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix

Blood coagulation & fibrinolysis, 1994-10, Vol.5 (5), p.755-760

1994

Volltextzugriff (PDF)

Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity

Blood, 1995, Vol.85 (1), p.121-129

1995

Volltextzugriff (PDF)

Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg

Thrombosis and haemostasis, 1985-01, Vol.53 (3), p.346-350

1985

Volltextzugriff (PDF)

F VIII subunits: purification and antigenic properties

Thrombosis and haemostasis, 1987-12, Vol.58 (4), p.1043-1048

1987

Volltextzugriff (PDF)

Radioimmunoassay for quantitative measurement of factor VIII‐heavy chain

British journal of haematology, 1988-03, Vol.68 (3), p.307-312

1988

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces

Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven)

Effect of leukocyte proteinases on tissue factor pathway inhibitor

Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A

Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions

The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits

Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae

Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven

Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa

Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins

Generation of active coagulation factor VIII from isolated subunits

Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma

Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin

Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa

Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits

Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin

The significance of TFPI in clotting assays--comparison and combination with other anticoagulants

Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin

The functional domains of coagulation factor VIII:C

Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays

Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix

Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity

Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg

F VIII subunits: purification and antigenic properties

Radioimmunoassay for quantitative measurement of factor VIII‐heavy chain

Suchergebnisse filtern